[{"id":"60ea72df-f2f1-426a-97fe-e1c86b6d2bac","acronym":"","url":"https://clinicaltrials.gov/study/NCT05187832","created_at":"2022-01-12T15:53:46.616Z","updated_at":"2024-07-02T16:35:17.085Z","phase":"Phase 1","brief_title":"A Study of AND019 in Women With ER Positive HER2 Negative Advanced or Metastatic Breast Cancer","source_id_and_acronym":"NCT05187832","lead_sponsor":"Kind Pharmaceuticals LLC","biomarkers":" HER-2 • ER","pipe":" | ","alterations":" HER-2 negative","tags":["HER-2 • ER"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e HER-2 negative"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e AND019"],"overall_status":"Recruiting","enrollment":" Enrollment 61","initiation":"Initiation: 10/05/2022","start_date":" 10/05/2022","primary_txt":" Primary completion: 05/01/2026","primary_completion_date":" 05/01/2026","study_txt":" Completion: 05/01/2026","study_completion_date":" 05/01/2026","last_update_posted":"2024-02-29"}]